Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Assessing the application of a pseudovirus system for emerging SARS-CoV-2 and re-emerging avian influenza virus H5 subtypes in vaccine development
Sheng-Wen Huang, Ching-Hui Tai, Yin-Mei Hsu, et al.
Biomedical Journal (2020) Vol. 43, Iss. 4, pp. 375-387
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
Bernadeta Dadonaite, Katharine H. D. Crawford, Caelan E. Radford, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1263-1278.e20
Open Access | Times Cited: 139
Construction and applications of SARS-CoV-2 pseudoviruses: a mini review
Minghai Chen, Xian‐En Zhang
International Journal of Biological Sciences (2021) Vol. 17, Iss. 6, pp. 1574-1580
Open Access | Times Cited: 93
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review
Yeqing Sun, Weijin Huang, Hongyu Xiang, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 554-554
Open Access | Times Cited: 6
Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles
Canhao Wu, Qin Xu, Huiyuan Wang, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 3, pp. 1523-1533
Open Access | Times Cited: 37
Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis
Yiling J. Cheng, Chiao-Hsuan Chao, Yen‐Chung Lai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Development and Application of a High-Titer VSV-Based HCoV-NL63 Pseudovirus System via C-terminal 14 amino acid Truncation of Spike
Liting Shao, Mingming Wang, Yiming Wang, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151458-151458
Closed Access
Inhibitory effect on SARS‐CoV‐2 infection of neferine by blocking Ca2+‐dependent membrane fusion
Yang Yang, Peng Yang, Cong Huang, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 10, pp. 5825-5832
Closed Access | Times Cited: 25
Pseudovirus-Based Systems for Screening Natural Antiviral Agents: A Comprehensive Review
Paola Trischitta, Maria Pia Tamburello, Assunta Venuti, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5188-5188
Open Access | Times Cited: 3
The Alarming Situation of Highly Pathogenic Avian Influenza Viruses in 2019–2023
Zhiwei Zhang, Zhao Lei
Global Medical Genetics (2024) Vol. 11, Iss. 03, pp. 200-213
Open Access | Times Cited: 3
Detection of live SARS-CoV-2 virus and its variants by specially designed SERS-active substrates and spectroscopic analyses
Jaya Sitjar, Jiunn‐Der Liao, Han Lee, et al.
Analytica Chimica Acta (2023) Vol. 1256, pp. 341151-341151
Open Access | Times Cited: 8
An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research
Peng Yang, Yang Yang, Yuming Wu, et al.
Journal of Virological Methods (2021) Vol. 295, pp. 114221-114221
Open Access | Times Cited: 16
Potential inhibitors for blocking the interaction of the coronavirus SARS-CoV-2 spike protein and its host cell receptor ACE2
Changzhi Li, Hongjuan Zhou, Lingling Guo, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Label-free SERS method with size-matched selectivity for analytes of varying sizes
Han Lee, Jiunn-Der Liao, Huey‐Pin Tsai, et al.
Surfaces and Interfaces (2023) Vol. 44, pp. 103821-103821
Closed Access | Times Cited: 6
Viral particle imaging by super-resolution fluorescence microscopy
Stefania Castelletto, Alberto Boretti
Chemical Physics Impact (2021) Vol. 2, pp. 100013-100013
Open Access | Times Cited: 15
Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2
Yong Guo, Jieru Meng, Jia‐Zheng Liu, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 9, pp. 885-885
Open Access | Times Cited: 15
Production and characterization of lentivirus vector-based SARS-CoV-2 pseudoviruses with dual reporters: Evaluation of anti-SARS-CoV-2 viral effect of Korean Red Ginseng
Jeonghui Moon, Younghun Jung, Seokoh Moon, et al.
Journal of Ginseng Research (2022) Vol. 47, Iss. 1, pp. 123-132
Open Access | Times Cited: 10
A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spike
Bernadeta Dadonaite, Katharine H. D. Crawford, Caelan E. Radford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Inactivation and Elimination of SARS-CoV-2 in Biosamples Using Simple Fixatives and Ultrafiltration
Ranjeet Kumar, Afsal Kolloli, Selvakumar Subbian
Methods and Protocols (2021) Vol. 4, Iss. 1, pp. 18-18
Open Access | Times Cited: 13
Nuclear Medicine in Times of COVID-19: How Radiopharmaceuticals Could Help to Fight the Current and Future Pandemics
Felix Neumaier, Boris D. Zlatopolskiy, Bernd Neumaier
Pharmaceutics (2020) Vol. 12, Iss. 12, pp. 1247-1247
Open Access | Times Cited: 11
Investigation of Avian Influenza H5N6 Virus-like Particles as a Broad-Spectrum Vaccine Candidate against H5Nx Viruses
Yu-Hsuan Yang, Ching-Hui Tai, Dayna Cheng, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 925-925
Open Access | Times Cited: 6
Bottom-up assembly of viral replication cycles
Oskar Staufer, Gösta Gantner, Ilia Platzman, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
Chiao-Hsuan Chao, Dayna Cheng, Sheng‐Wen Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Ceftazidime Is a Potential Drug to Inhibit SARS-CoV-2 Infection In Vitro by Blocking Spike Protein-ACE2 Interaction
Changdong Lin, Yue Li, MengYa Yuan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 6
The evolutionary footprint of influenza A subtype H3N2 strains in Bangladesh: implication of vaccine strain selection
Sezanur Rahman, Mehedi Hasan, Md. Shaheen Alam, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Pandemic number five – Latest insights into the COVID-19 crisis
Sophia Häfner
Biomedical Journal (2020) Vol. 43, Iss. 4, pp. 305-310
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top